Sanofi, Janssen ink pact to develop vaccine for extraintestinal pathogenic E. coli Ruchika Sharma4 Oct 2023 5:30 PM ISTSanofi will pay USD 175M upfront to Janssen, followed by development and commercial milestones.
Janssen seeks expanded USFDA approval for Rybrevant in combination with chemotherapy Ruchika Sharma29 Aug 2023 12:00 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental Biologics License ...
Phase 3 trial of Rybrevant plus chemotherapy in lung cancer meets primary endpoint: Janssen Ruchika Sharma18 July 2023 1:30 PM ISTNew Jersey: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the Phase 3 PAPILLON study ...
Janssen seeks USFDA nod for Carvykti for relapsed or refractory multiple myeloma Ruchika Sharma8 Jun 2023 12:30 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental Biologics License...
Janssen Milvexian gets USFDA fast track designation for Ischemic Stroke, Acute Coronary Syndrome, Atrial Fibrillation Ruchika Sharma26 May 2023 3:15 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced that all three prospective indications for milvexian, an ...
Janssen gets European Commission nod for AKEEGA to treat metastatic castration resistant prostate cancer with BRCA1/2 mutations Ruchika Sharma22 April 2023 11:32 AM ISTThe EC authorisation, which also marks the first worldwide approval for AKEEGA, is based on results of the randomised, double-blind, placebo...
Bristol Myers Squibb, Janssen launch Phase 3 Librexia clinical trial program evaluating Milvexian Ruchika Sharma5 March 2023 2:30 PM ISTPrinceton: Bristol Myers Squibb in collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson...
Janssen seeks USFDA nod for Niraparib and Abiraterone Acetate Dual-Action Tablet, plus Prednisone to treat patients with Metastatic Castration-Resistant Prostate Cancer with BRCA Gene Mutations Ruchika Sharma2 March 2023 3:15 PM ISTMetastatic castration-resistant prostate cancer characterizes cancer that no longer responds to androgen deprivation therapy and has spread to other...
Janssen, Global Partners to discontinue Phase 3 Mosaico HIV vaccine trial Ruchika Sharma19 Jan 2023 4:15 PM ISTLeiden: The Janssen Pharmaceutical Companies of Johnson & Johnson, together with a consortium of global partners, has announced the results of an...
Janssen seeks USFDA nod for Multiple myeloma treatment Talquetamab Ruchika Sharma11 Dec 2022 1:00 PM ISTRaritan, N.J.: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a Biologics License Application...
Janssen bags USFDA nod for IMBRUVICA for chronic graft-versus-host disease treatment Ruchika Sharma28 Aug 2022 12:45 PM ISTChronic graft-versus-host disease is a life-threatening complication that can occur after a stem cell or bone marrow transplant when newly...
Janssen bags USFDA nod for psoriatic arthritis treatment STELARA for pediatric patients Rahul Verma6 Aug 2022 8:16 PM ISTThe Janssen Pharmaceutical Companies of Johnson & Johnson has announced that the U.S. Food and Drug Administration (USFDA) has approved STELARA...
